Sanofi
Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases
Last updated:
Abstract:
The present invention provides substituted pyrido[2,3-d]pyrimidine compounds useful as inhibitors of protein kinases, pharmaceutically acceptable compositions thereof, and methods of using the same.
Status:
Grant
Type:
Utility
Filling date:
28 Aug 2018
Issue date:
14 Apr 2020